James Wilbur - 14 Sep 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Chief Commercial Officer
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for James Wilbur
Issuer symbol: TXG
Transactions as of: 14 Sep 2022
Net transactions value: $0
Form type: 4
Filing time: 16 Sep 2022, 17:32:22 UTC
Previous filing: 03 Aug 2022
Next filing: 23 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Award	$0	+95,839		$0.000000	95,839	14 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Award	$0	+239,596		$0.000000	239,596	14 Sep 2022	Class A Common Stock	239,596	$33.67	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 25% of the RSUs vest on the one-year anniversary measured from August 21, 2022, and 1/16th of the RSUs vest quarterly thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2	25% of the shares subject to the option vest on the one-year anniversary measured from July 27, 2022, and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person continuing as a service provider through each such date.